[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345614-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-345614-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","beyond-tumors-uninvolved-breast-tissue-enrichment-for-pathogenic-pik3ca-and-tp53-post-zygotic-variants-research-open-access","Beyond tumors - Uninvolved breast tissue enrichment for pathogenic PIK3CA and TP53 post-zygotic variants - Research Open Access","","Histologically normal mammary tissue from breast cancer patients can contain clinically meaningful genetic alterations that may arise before visible tumor development and shape disease progression. Whole-exome sequencing was applied to paired primary tumor and histologically normal mammary gland tissues from patients with poor prognosis, unselected patients, and non-cancer-related mammoplasty controls, using stringent variant filtering and duplex sequencing to confirm low-frequency pathogenic variants. Post-zygotic pathogenic variants in cancer genes were more prevalent in poor-prognosis patients, with truncating variants confined to this group and TP53 alterations linked to adverse outcomes, suggesting mosaic clonal evolution outside tumors.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/beyond-tumors-uninvolved-breast-tissue-enrichment-for-pathogenic-pik3ca-and-tp53-post-zygotic-variants-research-open-access/345614/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/beyond-tumors-uninvolved-breast-tissue-enrichment-for-pathogenic-pik3ca-and-tp53-post-zygotic-variants-research-open-access/345614.png","ImageObject",300,407,{"name":42,"@type":43},"Riley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study’s main aim regarding normal (uninvolved) breast tissue?","Question",{"text":63,"@type":64},"To determine whether histologically normal mammary tissue from breast cancer patients can harbor genetic alterations that may precede visible tumors and influence progression.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were genetic variants detected and validated in the study?",{"text":68,"@type":64},"Whole-exome sequencing with strict filtering was used, and duplex sequencing was applied to detect and confirm pathogenic PIK3CA and TP53 variants, including very low-frequency variants.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key findings about post-zygotic pathogenic variants in patients with poor prognosis?",{"text":72,"@type":64},"Cancer-associated post-zygotic pathogenic variants were more prevalent in normal mammary tissue of poor-prognosis patients than in unselected patients, with truncating variants restricted to poor-prognosis cases.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},345614,1790116378,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Andreou etal. BMC Cancer (2026) 26:753 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-16086-z](https://doi.org/10.1186/s12885-026-16086-z)  \nRESEARCH Open Access  \nBeyond tumors: uninvolved breast tissue  of breast cancer patients with adverse prognoses is enriched for pathogenic PIK3CA and TP53 post-zygotic variants  \nMaria Andreou1, Katarzyna Chojnowska1, Natalia Filipowicz 1, Monika Horbacz 1, Piotr Madanecki2, Katarzyna Duzowska1, Urszula Ławrynowicz1, Hanna Davies3, Bożena Bruhn-Olszewska3, Mikołaj Koszyński 1, Kinga Drężek-Chyła1, Maciej Jaśkiewicz1, Marcin Jąkalski1, Anna Kostecka 1, Marta Drzewiecka-Kłysz4, Magdalena Nowikiewicz5, Manuela Las-Jankowska6,7, Dariusz Bała6,8, Jacek Hoffman4, Ewa Śrutek9,10, Michał Jankowski6,8, Jerzy Jankau11, Diana Hodorowicz-Zaniewska12, Joanna Szpor13, Łukasz Szylberg10,14,  \nWojciech Zegarski6,8, Tomasz Nowikiewicz4,6, Patrick G. Buckley 15, Irene Tiemann-Boege 16, Jakub Mieczkowski1, Magdalena Koczkowska 1†, Jan P. Dumanski 1,3† and Arkadiusz Piotrowski1*†  \nAbstract  \nBackground Histologically normal mammary tissue from breast cancer patients can harbor significant genetic alterations that could precede visible tumor development and influence disease progression.  \nMethods Whole-exome sequencing was performed on 408 samples from 77 breast cancer patients with poor prognosis, 49 patients recruited without prognosis-based selection, and 15 individuals undergoing non-cancerrelated mammoplasty. Paired primary tumor and histologically normal mammary gland tissues were analyzed.  \nVariant classification adhered to strict filtering criteria, incorporating allele frequency thresholds, multiple annotation databases, and in silico prediction tools. Duplex sequencing was employed to detect and confirm pathogenic PIK3CA and TP53 variants in normal mammary tissue samples from 11 breast cancer patients with unfavorable prognosis. Statistical analyses included hypergeometric testing, Kaplan–Meier survival analysis, and Cox proportional hazards modeling.  \nResults Post-zygotic pathogenic variants in cancer-associated genes were significantly more prevalent in normal mammary tissue of poor-prognosis patients (29%) than in unselected patients (12 . 5%) (p = 0 . 0008578) . Variant presence and per-individual burden were similar across age-matched cohorts and intrinsic subtypes, indicating  \n†Arkadiusz Piotrowski, Jan P. Dumanski and Magdalena Koczkowska contributed equally to this work.  \n*Correspondence:  \nArkadiusz Piotrowski [arkadiusz.piotrowski@gumed.edu.pl](arkadiusz.piotrowski@gumed.edu.pl)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nAndreou et al. BMC Cancer (2026) 26:753 Page 2 of 13  \nthat subtype composition, germline predisposition and age do not account for the excess UM variant load in BCAP. Truncating variants were exclusive to poor-prognosis cases. Frequently altered genes included AKT1, PIK3CA, PTEN, TBX3, and TP53, with TP53 variants detected only in patients with adverse outcomes. Duplex sequencing","cbCaibbmxtEIEJRs","https://ap.wps.com/l/cbCaibbmxtEIEJRs","pdf",1991894,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background\n## Epidemiology and recurrence risk\n## Genetic contribution and sporadic disease\n## Rationale: molecular changes in normal mammary tissue","[{\"question\":\"What was the study’s main aim regarding normal (uninvolved) breast tissue?\",\"answer\":\"To determine whether histologically normal mammary tissue from breast cancer patients can harbor genetic alterations that may precede visible tumors and influence progression.\"},{\"question\":\"How were genetic variants detected and validated in the study?\",\"answer\":\"Whole-exome sequencing with strict filtering was used, and duplex sequencing was applied to detect and confirm pathogenic PIK3CA and TP53 variants, including very low-frequency variants.\"},{\"question\":\"What were the key findings about post-zygotic pathogenic variants in patients with poor prognosis?\",\"answer\":\"Cancer-associated post-zygotic pathogenic variants were more prevalent in normal mammary tissue of poor-prognosis patients than in unselected patients, with truncating variants restricted to poor-prognosis cases.\"}]","Beyond tumors - Uninvolved breast tissue enrichment for pathogenic PIK3CA and TP53 post-zygotic variants - Research Open Access | PDF",1790058327,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92edba98d63c6d0c41203711fa70a904.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3d7cb5e938b87f06dddd538921cf8ea.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/72e5297e159bbafab6748c4255cd2ffd.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68ca61ad52b8e21369d80e65e1d67a59.webp",980,1306]